Network

Ole Winther

Person: VIP

Thomas Urup

  • University of Copenhagen
  • Copenhagen University Hospital - Rigshospitalet

External person

Iben Spanggaard

  • Copenhagen University Hospital - Rigshospitalet
  • University of Copenhagen

External person

Antoine Italiano

  • Université de Bordeaux
  • Centre Georges-François Leclerc
  • Institut Gustave Roussy

External person

Lise Barlebo Ahlborn

  • Kobenhavns Universitet
  • Copenhagen University Hospital - Rigshospitalet
  • University of Copenhagen

External person

Christina Westmose Yde

  • Institut for Biokemi og Molekylær Biologi
  • Copenhagen University Hospital - Bispebjerg and Frederiksberg
  • Copenhagen University Hospital - Rigshospitalet
  • University of Copenhagen

External person

Jan H M Schellens

  • Netherlands Cancer Institute
  • Synthon BV

External person

Enriqueta Felip

  • Autonomous University of Barcelona

External person

Ida Viller Tuxen

  • Copenhagen University Hospital - Rigshospitalet

External person

Shivaani Kummar

  • Oregon Health and Science University
  • Stanford University
  • Harvard University

External person

Jesus Garcia-Foncillas

  • University Hospital Fundación Jiménez Díaz
  • Universidad Autónoma de Madrid

External person

Vibeke Andrée Larsen

  • University of Copenhagen
  • Copenhagen University Hospital - Rigshospitalet
  • Copenhagen University Hospital - Bispebjerg and Frederiksberg

External person

Alexander Drilon

  • Memorial Sloan-Kettering Cancer Center
  • Cornell University

External person

Dorte Schou Nørøxe

  • University of Copenhagen

External person

Noman Paracha

  • Bayer AG
  • Bayer Pharmaceut

External person

Morten Mau-Sørensen

  • Copenhagen University Hospital - Rigshospitalet

External person

Ghazaleh Tabatabai

  • University of Tübingen
  • German Cancer Research Center

External person

Christina W. Yde

  • University of Southern Denmark
  • University of Copenhagen
  • Danish Cancer Society

External person

Maria Martinez-Garcia

  • Pompeu Fabra University

External person

Hendrik-Tobias Arkenau

  • University College London

External person

Kristoffer Rohrberg

  • Copenhagen University Hospital - Rigshospitalet

External person

Christina Westmose Yde

  • Copenhagen University Hospital - Rigshospitalet

External person

Josep Tabernero

  • Sheba Medical Center at Tel Hashomer
  • Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Vall d'Hebron, Barcelona, Spain.

External person

Wolfgang Jacob

  • F. Hoffmann-La Roche

External person

Gilles Vassal

  • Université Paris-Sud
  • Université Paris-Saclay
  • Institut Gustave Roussy

External person

Didier Meulendijks

  • Netherlands Cancer Institute

External person

Katrine Toubro Gad

  • Copenhagen University Hospital - Rigshospitalet

External person

Martin Weisser

  • F. Hoffmann-La Roche

External person

Maja J A de Jonge

  • Erasmus University Rotterdam

External person

P Dombernowsky

  • University of Copenhagen

External person

Carsten Bokemeyer

  • University Medical Center Hamburg-Eppendorf
  • University of Hamburg

External person

Steinbjørn Hansen

  • University of Southern Denmark
  • Sydvestjysk Hospital, Esbjerg, Denmark; Odense University Hospital, Odense, Denmark.

External person

Sean D Sullivan

  • University of Washington
  • Fred Hutchinson Cancer Research Center
  • The Leona M. and Harry B. Helmsley Charitable Trust

External person

David S Hong

  • University of Texas MD Anderson Cancer Center

External person

Francesca Michielin

  • F. Hoffmann-La Roche

External person

Celine Adessi

  • F. Hoffmann-La Roche

External person

Andrés Cervantes

  • Nutrition and Food Science Area

External person

Ian R. James

  • A4P Consulting Ltd

External person

Maurizio Ceppi

  • F. Hoffmann-La Roche

External person

Jordi Rodon

  • Autonomous University of Barcelona
  • University of Texas MD Anderson Cancer Center

External person

Vivek Subbiah

  • University of Texas MD Anderson Cancer Center

External person

Emile E Voest

  • Antoni van Leeuwenhoek Hospital
  • Netherlands Cancer Institute

External person

Tania Fleitas Kanonnikoff

  • Nutrition and Food Science Area

External person

Lise B Ahlborn

  • University of Copenhagen
  • Copenhagen University Hospital - Rigshospitalet

External person

Ane Yde Schmidt

  • Copenhagen University Hospital - Rigshospitalet
  • University of Copenhagen

External person

Savvas Kinalis

  • University of Copenhagen
  • Copenhagen University Hospital - Rigshospitalet
  • Copenhagen University Hospital - Bispebjerg and Frederiksberg

External person

Annie Borch

  • Technical University of Denmark

External person

Jean-Charles Soria

  • Institut Gustave Roussy
  • Université Paris-Saclay

External person

Lillian L Siu

  • University Health Network
  • University Health Network

External person

Zev A Wainberg

  • University of California at Los Angeles

External person

Britta Bjerregaard Jensen

  • Aalborg University

External person

Serge Leyvraz

  • Charité – Universitätsmedizin Berlin

External person

Simone Maarup

  • University of Copenhagen

External person

Marc Fellous

  • Bayer AG
  • Medignition Inc.

External person

Georgina Meneses-Lorente

  • F. Hoffmann-La Roche

External person

Jean-Yves Blay

  • Université Claude Bernard & Centre Léon Bérard
  • Universite Claude Bernard Lyon 1

External person

Rodrigo Dienstmann

  • Oncoclínicas Precision Medicine

External person

Andreas von Deimling

  • Heidelberg University 
  • German Cancer Research Center
  • Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ)

External person

Marcia S Brose

  • University of Pennsylvania
  • Thomas Jefferson University

External person

Tilde Dombernowsky

  • University of Copenhagen

External person

Albrecht Stenzinger

  • Heidelberg University 
  • Centers for Personalized Medicine (ZPM)

External person

Wolfgang Wick

  • Heidelberg University 
  • German Cancer Research Center

External person

Morten Mau-Sorensen

  • University of Copenhagen

External person

Catherine Bresson

  • Worldwide Innovative Network (WIN) Association

External person

Mikkel Christian Alanin

  • University of Copenhagen

External person

Hans-Georg Rammensee

  • University of Tübingen
  • German Cancer Research Center

External person

Ioana Berindan-Neagoe

  • Iuliu Hatieganu University of Medicine and Pharmacy

External person

Francisco Martínez-Ricarte

  • Autonomous University of Barcelona
  • Hospital Universitario La Fe

External person

Paul J. Burgess

  • Cranfield University

External person

Richard L. Schilsky

  • Worldwide Innovative Network (WIN) Association

External person

Laila Belcaid

  • Copenhagen University Hospital - Rigshospitalet

External person

Nicolas Girard

  • Institut Curie

External person

Ricarda Norenberg

  • Chrestos Concept GmbH & Co. KG

External person

Daniel S. W. Tan

  • National Cancer Centre

External person

Erin R Rudzinski

  • University of Washington

External person

Norbert Hilf

  • Immatics Biotechnologies GmbH

External person

Jane Skjøth-Rasmussen

  • University of Copenhagen
  • Copenhagen University Hospital - Rigshospitalet

External person

Brian M. Slomovitz

  • University of Miami
  • Florida International University

External person

Bracha Shraibman

  • Technion-Israel Institute of Technology

External person

Thierry Philip

  • Institut Curie

External person

Angel Porgador

  • Ben-Gurion University of the Negev

External person

Kenneth Francis Hofland

  • Copenhagen University Hospital - Rigshospitalet
  • University of Copenhagen

External person

Jean-Pascal Machiels

  • Cliniques Universitaires Saint-Luc
  • Université catholique de Louvain

External person

Sabrina Kuttruff-Coqui

  • Immatics Biotechnologies GmbH

External person

Eitan Rubin

  • Ben-Gurion University of the Negev

External person

Berta Ponsati

  • BCN Peptides

External person

Migle Gabrielaite

  • Copenhagen University Hospital - Rigshospitalet

External person

Sebastian Kreiter

  • BioNTech Ag
  • working group Cancer Immunoguiding Program

External person

Camilla Klausen

  • University of Copenhagen
  • Copenhagen University Hospital - Amager and Hvidovre

External person

Giuseppe Curigliano

  • University of Milan
  • IRCCS Istituto Europeo di Oncologia - Milano

External person

Juan Miguel Cejalvo

  • Nutrition and Food Science Area

External person

Johann S de Bono

  • Institute of Cancer Research
  • The Institute of Cancer Research, London
  • Department of Palliative Medicine, Royal Marsden Hospital, London

External person

Nicole Concin

  • KU Leuven
  • Innsbruck Medical University
  • BGOG and Catholic University of Leuven

External person

Dorte Schou Nørøxe

  • Copenhagen University Hospital - Rigshospitalet
  • University of Copenhagen

External person

Martin David Forster

  • University College London

External person

Theodore W Laetsch

  • University of Texas Southwestern Medical Center
  • University of Pennsylvania

External person

Alexander Stein

  • University of Hamburg

External person

C. S. Pramesh

  • Tata Memorial Hospital

External person

Sjoerd H. van der Burg

  • working group Cancer Immunoguiding Program
  • Leiden University

External person

Lars Damstrup

  • Merck KGaA
  • DebioPharm SA

External person

Amal Al-Omari

  • King Hussein Cancer Center

External person

Christina Westmose Yde

  • Copenhagen University Hospital - Bispebjerg and Frederiksberg
  • University of Copenhagen
  • Copenhagen University Hospital - Rigshospitalet

External person

Victor Moreno

  • Bellvitge Biomedical Research Institute
  • Institute Catala Oncologia
  • Instituto de Salud Carlos III
  • University of Barcelona
  • Universidad Autónoma de Madrid

External person

Katrin Frenzel

  • BioNTech Ag
  • Neuruppin Bonn

External person

Michael Weller

  • University of Zurich
  • University Hospital Zürich

External person

Christophe Massard

  • Institut Gustave Roussy
  • University of Dundee

External person

Pierre Yves Dietrich

  • University of Geneva

External person

Gerald Batist

  • McGill University

External person

Lin Shen

  • Peking University

External person

Ian Buysschaert

  • General Hospital St. Jan

External person

Monique C Minnema

  • Utrecht University

External person

Judith R. Kroep

  • Leiden University

External person

Valerie Dutoit

  • University of Geneva

External person

Juan Sahuquillo

  • Autonomous University of Barcelona

External person

Patrick Roth

  • University Hospital Zürich

External person

Patrick Y Wen

  • Harvard University
  • Dana-Farber Cancer Institute

External person

Sadakatsu Ikeda

  • Institute of Science Tokyo

External person

Fiona C. Thistlethwaite

  • University of Manchester

External person

John A. Reeves

  • Bayer AG
  • Bayer HealthCare Pharmaceuticals Inc.

External person

John C. Castle

  • BioNTech Ag
  • Agenus

External person

Cedrik M. Britten

  • BioNTech Ag
  • working group Cancer Immunoguiding Program
  • GlaxoSmithKline

External person

Razelle Kurzrock

  • Worldwide Innovative Network (WIN) Association

External person

Michael Platten

  • Heidelberg University 
  • German Cancer Research Center

External person

Paul G Richardson

  • Dana-Farber Cancer Institute

External person

Jacques Raynaud

  • Worldwide Innovative Network (WIN) Association

External person

James F. Spicer

  • Guy's and St Thomas' NHS Foundation Trust

External person

Hideho Okada

  • University of California San Francisco
  • Parker Institute for Cancer Immunotherapy

External person

Shai Magidi

  • Worldwide Innovative Network (WIN) Association

External person

David M Hyman

  • Memorial Sloan-Kettering Cancer Center
  • Cornell University
  • Loxo Oncology, Inc.

External person

Ugur Sahin

  • BioNTech Ag

External person

Mats Holmberg

  • University of Gothenburg
  • Karolinska University Hospital

External person

Torben Plesner

  • University of Southern Denmark

External person

Arie Admon

  • Technion-Israel Institute of Technology

External person

Alberto S Pappo

  • St. Jude Children Research Hospital

External person

Colette Song

  • Immatics Biotechnologies GmbH

External person

Amir Onn

  • Sheba Medical Center at Tel Hashomer

External person

E S M Yuen

  • Eli Lilly

External person

Susan Galbraith

  • AstraZeneca, UK

External person

Max Hasmann

  • F. Hoffmann-La Roche

External person

Noah Federman

  • University of Washington
  • University of California at Los Angeles

External person

Christian H. Ottensmeier

  • University of Southampton
  • University of Liverpool
  • La Jolla Institute for Allergy and Immunology

External person

Filippo de Braud

  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano

External person

Sharon Shacham

  • Karyopharm Therapeutics

External person

Gerhard Niederfellner

  • Beoro Therapeutics GmbH

External person

Oliver Bahr

  • Goethe University Frankfurt

External person

Ray McDermott

  • Trinity College Dublin
  • Cancer Trials Ireland
  • University College Dublin
  • Adelaide and Meath Hospital (Incorporating the National Children's Hospital)

External person

James Vasquez

  • GlaxoSmithKline

External person

Anna Spreafico

  • University Health Network

External person

Volker Heinemann

  • Ludwig Maximilian University of Munich

External person

Samuel A. Funt

  • Cornell University
  • Memorial Sloan-Kettering Cancer Center

External person

J. Merchan

  • University of Miami

External person

Patrick A. Ott

  • Dana-Farber Cancer Institute
  • Harvard University

External person

Eva Wardelmann

  • University of Münster

External person

Henrik Pagh Schultz

  • Institut for Klinisk Medicin - Onkologisk Afdeling D, NBG

External person

Niels W C J van de Donk

  • Vrije Universiteit Amsterdam
  • Amsterdam UMC

External person

Alexander Upton

  • Bayer Healthcare Pharmaceuticals

External person

Tine Holm Riis

  • University of Copenhagen

External person

S. Pakola

  • University of Helsinki

External person

Asbjørn Høegholm

  • University of Copenhagen
  • Copenhagen University Hospital - Næstved, Slagelse and Ringsted

External person

Martin Schuler

  • University Hospital Essen

External person

Kenneth F. Hofland

  • Copenhagen University Hospital - Rigshospitalet

External person

Marianne Ingerslev Holt

  • Sygehus Lillebælt

External person

Asgeir Sigurdsson

  • deCODE Genetics

External person

Andreas Arendtsen Rostved

  • University of Copenhagen

External person

Frederick Klauschen

  • Charité – Universitätsmedizin Berlin
  • German Cancer Research Center
  • BIFOLD – Berlin Institute for the Foundations of Learning and Data
  • Ludwig Maximilian University of Munich

External person

Alejandro Navarro Mendivil

  • Autonomous University of Barcelona

External person

Kay Tatsuoka

  • Bristol-Myers Squibb

External person

Jon H Olafsson

  • Islandic Meteorological Organisation
  • University of Iceland
  • Landspitali University Hospital

External person

Thomas Kirchner

  • Ludwig Maximilian University of Munich

External person

Vinicius Tragante

  • Utrecht University
  • deCODE Genetics
  • University of Iceland

External person

Nina Pawlowski

  • Immatics Biotechnologies GmbH

External person

Natasha Leighl

  • University of Toronto
  • University Health Network

External person

Mie Grunnet

  • Copenhagen University Hospital - Rigshospitalet

External person

Michael C. Burger

  • Goethe University Frankfurt

External person

Catherine J Harmer

  • University of Oxford
  • Oxford Health NHS Foundation Trust
  • Warneford Hospital

External person

René K Olesen

  • Institut for Klinisk Medicin - Onkologisk Afdeling D, NBG

External person

Masafumi Ikeda

  • National Cancer Center Hospital East

External person

Jane Skjøth-Rasmussen

  • Copenhagen University Hospital - Rigshospitalet

External person

Jörg Ludwig

  • Immatics Biotechnologies GmbH

External person

Iria Gonzalez

  • Pompeu Fabra University

External person

Klaus Richter Larsen

  • Copenhagen University Hospital - Bispebjerg and Frederiksberg

External person

Li Yan

  • Hebei Medical University
  • GlaxoSmithKline
  • Beijing Normal University

External person

T. Niskanen

  • University of Helsinki

External person

Stefan Stevanović

  • University of Tübingen
  • German Cancer Research Center

External person

Annie Moisan

  • F. Hoffmann-La Roche

External person

Claudia Wagner

  • Immatics Biotechnologies GmbH
  • Leibniz Institute for the Social Sciences
  • RWTH Aachen University
  • Complexity Science Hub Vienna

External person

R. L. Eefsen

  • University of Copenhagen
  • Herlev Gentofte Hospital

External person

Joan Albanell

  • Pompeu Fabra University

External person

Tjoung-Won Park-Simon

  • Hannover Medical School

External person

Nuno Sousa

  • Instituto Português de Oncologia do Porto Francisco Gentil E.P.E.

External person

Gregory G. Oakley

  • University of Nebraska Medical Center

External person

Jordan Berlin

  • Sun Microsystems

External person

Mev Dominguez-Valentin

  • University of Oslo
  • Berkshire Healthcare NHS Foundation Trust
  • CALEDONIAN EXCHANGE
  • European Hereditary Tumour Group (EHTG)
  • Oslo University Hospital

External person

Morten Mau-Sørensen

  • University of Copenhagen
  • Kobenhavns Universitet

External person

Trausti Valdimarsson

  • Glaesibaer Centre
  • West Iceland Healthcare Centre

External person

Alvaro Taus Garcia

  • Pompeu Fabra University

External person

Julius Gudmundsson

  • deCODE Genetics

External person

Frédérique M Penault-Llorca

  • Centre Jean Perrin
  • Université Clermont Auvergne
  • Imagerie Moléculaire et Stratégies Théranostiques (IMoST)

External person

Lise Bjerrum Thisted

  • Copenhagen University Hospital - Rigshospitalet
  • The Finsen Laboratory
  • Copenhagen University Hospital - Næstved, Slagelse and Ringsted

External person

Lise Barlebo Ahlborn

  • Copenhagen University Hospital - Bispebjerg and Frederiksberg

External person

Franziska Hoffgaard

  • Immatics Biotechnologies GmbH

External person

Magnus I. Magnusson

  • deCODE Genetics

External person

Jonathan D. Trent

  • University of Miami

External person

Catya Munhoz

  • Bayer HealthCare

External person

Antonio Calles

  • Université Paris-Saclay
  • Hospital General Universitario Gregorio Marañon

External person

Mikkel Seidelin Dam

  • Copenhagen University Hospital - Rigshospitalet

External person

David A. Reardon

  • Harvard University

External person

Brian B Tuch

  • Applied Biosystems Part of Life Technologies

External person

Christiane E Mortensen

  • Department of Oncology

External person

Pål Moller

  • University of Oslo

External person

Saedis Saevarsdottir

  • Karolinska Institutet
  • University of Iceland
  • deCODE Genetics
  • Landspitali University Hospital

External person

Monika Stieglbauer

  • University of Tübingen
  • working group Cancer Immunoguiding Program

External person

Mads Daugaard

  • Vancouver Prostate Centre
  • University of British Columbia
  • Vancouver Coastal Health

External person

Emma Dean

  • Université catholique de Louvain

External person

Vibeke A Larsen

  • Copenhagen University Hospital - Rigshospitalet
  • University of Copenhagen

External person

Carolina Barra

  • Universidad Nacional de San Martin
  • Instituto de Investigaciones Biotecnológicas - Instituto Tecnológico Chascomús
  • Technical University of Denmark

External person

Mirko Fillbrunn

  • Analysis Group Inc.

External person

Eric Vail

  • Cedars-Sinai Medical Center

External person

Louise Holmquist

  • Scania Regional Council
  • Genomic Medicine Sweden (GMS)

External person

Catherine Alix-Panabières

  • CHU Montpellier
  • University of Montpellier

External person

Annika Loft

  • Copenhagen University Hospital - Rigshospitalet
  • University of Copenhagen

External person

Bjarni A Agnarsson

  • Landspitali University Hospital
  • University of Iceland

External person

Ira Pastan

  • National Institutes of Health

External person

Steinn Jonsson

  • University of Iceland
  • Landspitali University Hospital

External person

Sandra Heesch

  • BioNTech Ag

External person

Cornelis M. van Tilburg

  • German Cancer Research Center

External person

Christoph Huber

  • BioNTech Ag
  • Vienna University of Economics and Business

External person

Annika Loft Jakobsen

  • University of Copenhagen

External person

Matthew Taylor

  • University of Colorado Boulder

External person

Valérie Méresse Naegelen

  • F. Hoffmann-La Roche

External person

Michael Hummel

  • Charité – Universitätsmedizin Berlin
  • Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie NOGGO e. V
  • Helmholtz Zentrum München - German Research Center for Environmental Health

External person

Jonas Leichsenring

  • Heidelberg University 

External person

Regina Mendrzyk

  • Immatics Biotechnologies GmbH

External person

Reinhard Büttner

  • University of Cologne

External person

Trine Heide Øllegaard

  • Aarhus University Hospital
  • Aarhus University

External person

Oleksandr Frei

  • University of Oslo

External person

Manfred Dietel

  • Quality Initiative in Pathology (QuiP)

External person

Filip Janku

  • University of Texas MD Anderson Cancer Center

External person

Christian Erikstrup

  • Aarhus University
  • Aarhus University Hospital
  • University of Copenhagen

External person

Kathryn H Brown

  • University of California at Davis

External person

Carsten Reinhardt

  • Immatics Biotechnologies GmbH

External person

Anders Edsjö

  • Scania Regional Council
  • Lund University
  • Genomic Medicine Sweden (GMS)

External person

Dearbhaile Collins

  • Cork University Hospital

External person

Albiruni R Abdul Razak

  • University Health Network
  • Princess Margaret Cancer Center

External person

Veronique Dieras

  • Institut Curie

External person

Marcos Tatagiba

  • University of Tübingen

External person

Niels Pallisgaard

  • Zealand University Hospital - Køge
  • Zealand University Hospital - Roskilde
  • Zealand Univ Hosp, Dept Pathol
  • Sjællands Universitetshospital

External person

Lars Henrik Jensen

  • Vejle Sygehus
  • Sydvestjysk Hospital, Esbjerg, Denmark; Odense University Hospital, Odense, Denmark.

External person

Idrees Mian

  • National Institutes of Health

External person

Sabine Merkelbach-Bruse

  • University of Cologne

External person

Wolfgang Dietmaier

  • University of Regensburg

External person

Garðar Sveinbjörnsson

  • deCODE Genetics
  • University of Iceland

External person

C. Even

  • Institut Gustave Roussy

External person

Yongmei Liu

  • Wake Forest University
  • Duke University
  • Sichuan University

External person

Elisabeth W Andersen

  • Technical University of Denmark
  • Danish Cancer Institute

External person

Martina Kirchner

  • Heidelberg University 

External person

Leo Mascarenhas

  • University of Southern California

External person

Anas Gazzah

  • Institut Gustave Roussy

External person

Karen Wang

  • Novartis USA
  • University of Michigan, Ann Arbor

External person

Daniel Morgensztern

  • Washington University School of Medicine

External person

Jean Pierre Delord

  • IUCT-Oncopole
  • Institut Claudius Regaud

External person

Gilberto Castro

  • Universidade de São Paulo

External person

Robert Zachariae

  • Aarhus University
  • Danish Breast Cancer Group Center and Clinic for Late Effects
  • Danish Breast Cancer Group
  • Aarhus University Hospital

External person

Annika Eigtved

  • University of Copenhagen

External person

Frederik Marme

  • Heidelberg University 

External person

Eivind Hovig

  • University of Oslo

External person

V. Lazar

  • Institut Gustave Roussy
  • Université Paris-Saclay
  • Functional Genomic Unit
  • Worldwide Innovative Network (WIN) Association

External person

Atrayee Basu Mallick

  • Thomas Jefferson University

External person

Martin R Larsen

  • University of Southern Denmark

External person

Douglas S Hawkins

  • University of Washington

External person

Annika Lehmann

  • Charité – Universitätsmedizin Berlin

External person

Snaedis Kristmundsdottir

  • deCODE Genetics
  • Reykjavík University

External person

Nina Karaseva

  • St. Petersburg City Oncology Dispensary

External person

Jessica Lin

  • New York University
  • Harvard University

External person

Volker Endris

  • Heidelberg University 

External person

Sascha Dietrich

  • Heidelberg University 
  • Heinrich Heine University Düsseldorf
  • European Society for Blood and Marrow Transplantation

External person

Alexandra Havdahl

  • Norwegian Institute of Public Health
  • Lovisenberg Diaconal Hospital
  • University of Oslo
  • Lovisenberg Diaconal Hospitaland
  • University Hospital Essen

External person